Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-06

Clinical Trial Update: AIN Transfer for Cubital Tunnel Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating AIN transfer for cubital tunnel syndrome has completed, sponsored by the University of Alberta.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AIN transfer

Snippet

Sponsor: University of Alberta | Conditions: Nerve Injury, Surgery | Phase 1, Phase 2 | Status: COMPLETED